Circulation, Vol 84, 2091-2100, Copyright © 1991 by American Heart Association
MB Patel, JM Stewart, AV Loud, P Anversa, J Wang, L Fiegel and TH Hintze
BACKGROUND. We have previously shown that chronic elevation of plasma
norepinephrine leads to a functional independent increase in left
ventricular weight. The goals of the present study were to determine
quantitatively the component of the myocardium that accounted for the
observed structural changes and to determine the function of the
hypertrophied myocardium. METHODS AND RESULTS. Mongrel dogs were
chronically instrumented for measurement of arterial and left ventricular
pressures, left ventricular internal diameter, and left ventricular wall
thickness. Subcutaneous osmotic pumps were implanted to release
norepinephrine continuously for 28 days. Hemodynamics were measured with
dogs in the quietly resting state and during infusions of isoproterenol at
0.1 and 0.5 micrograms/kg/min before and on days 14 and 28 during the
infusion of norepinephrine. The hemodynamic response to 10 micrograms/kg
phenylephrine, given as a bolus, was also assessed before norepinephrine
and 28 days during the infusion of norepinephrine, and the end-systolic
pressure-diameter or wall-stress- diameter relations were calculated. On
day 28, hearts were arrested in diastole and perfusion fixed in situ.
Tissue samples were prepared for electron microscopy and morphometry.
Hemodynamic studies showed that isoproterenol (0.5 micrograms/kg/min)
reduced mean arterial pressure (MAP) to the same point on each experimental
day, and the increases in indexes of contractility were reduced during
norepinephrine infusion. Left ventricular dP/dtmax increased 131 +/- 24% on
control day, only 67 +/- 20% on day 14, and 55 +/- 18% on day 28. Similar
changes were observed in dP/dt/DP40 and dP/dt/end-diastolic circumference.
However, Emax, the slope of the end-systolic pressure-diameter or wall
stress diameter relations, was unchanged, suggesting that inotropic state
was not altered. Morphometric studies showed that the cross-sectional area
of myocytes increased by 55%, but myocyte and capillary densities decreased
by 34% and 29%, respectively (p less than 0.05) in dogs with high
norepinephrine levels. There were no differences in volume fractions of
myocytes, capillary lumen, or interstitium or capillary-to- myocyte ratio.
CONCLUSIONS. The myocardium of dogs with high norepinephrine levels shows
reduced inotropic response to beta- adrenergic stimulation despite the
increases in left ventricular mass and left ventricular wall thickness,
which are a result of growth of the cardiac myocytes and characteristic of
concentric hypertrophy. These data suggest that chronic adrenergic
stimulation of the heart reduces the beta-receptor coupling to the
contractile response without importantly compromising left ventricular
function.
ARTICLES
Altered function and structure of the heart in dogs with chronic elevation in plasma norepinephrine
Department of Physiology, New York Medical College, Valhalla 10595.
This article has been cited by other articles:
![]() |
R. Yang and L. A. Barouch Leptin Signaling and Obesity: Cardiovascular Consequences Circ. Res., September 14, 2007; 101(6): 545 - 559. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Seals and F. A. Dinenno Collateral damage: cardiovascular consequences of chronic sympathetic activation with human aging Am J Physiol Heart Circ Physiol, November 1, 2004; 287(5): H1895 - H1905. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Nikolaidis, D. Trumble, T. Hentosz, A. Doverspike, R. Huerbin, M. A. Mathier, Y.-T. Shen, and R. P. Shannon Catecholamines restore myocardial contractility in dilated cardiomyopathy at the expense of increased coronary blood flow and myocardial oxygen consumption (MvO2 cost of catecholamines in heart failure) Eur J Heart Fail, June 1, 2004; 6(4): 409 - 419. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Schlaich, D. M. Kaye, E. Lambert, M. Sommerville, F. Socratous, and M. D. Esler Relation Between Cardiac Sympathetic Activity and Hypertensive Left Ventricular Hypertrophy Circulation, August 5, 2003; 108(5): 560 - 565. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sherwood, E. C. D. Gullette, A. L. Hinderliter, A. Georgiades, M. Babyak, R. A. Waugh, and J. A. Blumenthal Relationship of Clinic, Ambulatory, and Laboratory Stress Blood Pressure to Left Ventricular Mass in Overweight Men and Women With High Blood Pressure Psychosom Med, March 1, 2002; 64(2): 247 - 257. [Abstract] [Full Text] |
||||
![]() |
F. Leon-Velarde, M.-C. Bourin, R. Germack, K. Mohammadi, B. Crozatier, and J.-P. Richalet Differential alterations in cardiac adrenergic signaling in chronic hypoxia or norepinephrine infusion Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2001; 280(1): R274 - R281. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. W. Kamarck, J. Eranen, J. R. Jennings, S. B. Manuck, S. A. Everson, G. A. Kaplan, and J. T. Salonen Anticipatory Blood Pressure Responses to Exercise Are Associated With Left Ventricular Mass in Finnish Men : Kuopio Ischemic Heart Disease Risk Factor Study Circulation, September 19, 2000; 102(12): 1394 - 1399. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yonemochi, S. Yasunaga, Y. Teshima, N. Takahashi, M. Nakagawa, M. Ito, and T. Saikawa Rapid Electrical Stimulation of Contraction Reduces the Density of {beta}-Adrenergic Receptors and Responsiveness of Cultured Neonatal Rat Cardiomyocytes : Possible Involvement of Microtubule Disassembly Secondary to Mechanical Stress Circulation, June 6, 2000; 101(22): 2625 - 2630. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. White, R. J. Wiechmann, R. L. Roden, M. B. Hagan, M. M. Wollmering, J. D. Port, E. Hammond, W. T. Abraham, E. E. Wolfel, J. Lindenfeld, et al. Cardiac ß-Adrenergic Neuroeffector Systems in Acute Myocardial Dysfunction Related to Brain Injury : Evidence for Catecholamine-Mediated Myocardial Damage Circulation, October 15, 1995; 92(8): 2183 - 2189. [Abstract] [Full Text] |
||||
![]() |
J. Kajstura, X. Zhang, Y. Liu, E. Szoke, W. Cheng, G. Olivetti, T. H. Hintze, and P. Anversa The Cellular Basis of Pacing-Induced Dilated Cardiomyopathy : Myocyte Cell Loss and Myocyte Cellular Reactive Hypertrophy Circulation, October 15, 1995; 92(8): 2306 - 2317. [Abstract] [Full Text] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1991 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |